ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

STEVEN RODRIGUEZ MONGE MD

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,474Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 551

$805K Total Retail Price of All Prescriptions

Rank: 31 out of 551

610 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
2% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 610 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 16,639 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $35 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 1,167 952 1 1
RANITIDINE HCL 960 718 2 8
AMLODIPINE BESYLATE 735 587 3 4
LEVOTHYROXINE SODIUM 654 519 4 9
LOSARTAN POTASSIUM 542 450 5 6
METFORMIN HCL ER 541 395 6 67
GABAPENTIN 497 387 7 3
ENALAPRIL MALEATE 476 398 8 5
SYNTHROID 471 353 9 11
FUROSEMIDE 432 314 10 13
OMEPRAZOLE 424 361 11 7
PRAVASTATIN SODIUM 371 277 12 24
GLYBURIDE-METFORMIN HCL 306 221 R 13 48
LOSARTAN-HYDROCHLOROTHIAZIDE 301 260 14 10
ZOLPIDEM TARTRATE 300 226 15 27
HYDROCHLOROTHIAZIDE 299 250 16 15
LISINOPRIL 295 182 17 14
METOPROLOL TARTRATE 285 217 18 17
GLIMEPIRIDE 284 199 19 16
TRAMADOL HCL-ACETAMINOPHEN 283 210 20 18
ATENOLOL 267 166 21 12
HUMULIN 70-30 266 213 22 35
FENOFIBRATE 258 146 23 34
METFORMIN HCL 238 176 24 2
ATORVASTATIN CALCIUM 220 154 25 29
ALENDRONATE SODIUM 216 152 26 19
SERTRALINE HCL 214 184 27 43
IRBESARTAN 206 159 28 51
NABUMETONE 197 154 29 37
JANUVIA 193 124 30 87
DOXAZOSIN MESYLATE 190 182 31 25
SINGULAIR 184 135 32 58
METOPROLOL SUCCINATE 171 159 33 23
TAMSULOSIN HCL 162 136 34 38
VERAPAMIL ER 159 143 35 39
CARVEDILOL 159 136 35 22
ISOSORBIDE MONONITRATE ER 158 139 37 21
FAMOTIDINE 154 115 38 31
WARFARIN SODIUM 153 117 39 46
MELOXICAM 148 114 40 90
CAPTOPRIL 142 122 41 63
DIOVAN 132 105 42 57
CLOPIDOGREL 129 107 43 30
RAMIPRIL 129 101 43 53
ASPIRIN EC 118 92 45 26
MECLIZINE HCL 118 112 45 56
ZETIA 116 99 47 69
FINASTERIDE 116 106 47 82
GLIPIZIDE XL 115 112 49 81
PAROXETINE HCL 114 90 50 77
INSULIN SYRINGE 113 80 51 41
LACTULOSE 110 83 52 162
PANTOPRAZOLE SODIUM 106 70 53 36
CLONIDINE HCL 99 74 54 60
AMLODIPINE BESYLATE-BENAZEPRIL 98 71 55 42
CILOSTAZOL 97 95 56 64
TRAMADOL HCL 96 72 57 32
DILTIAZEM 24HR CD 96 78 57 98
LYRICA 94 66 59 86
CLOTRIMAZOLE-BETAMETHASONE 92 78 60 49
EVISTA 89 77 61 52
DIGOXIN 84 74 62 44
LOVASTATIN 83 77 63 68
ACTOS 80 47 64 135
ADVAIR DISKUS 79 46 65 97
ETODOLAC 78 54 66 95
LATANOPROST 78 78 66 121
AVAPRO 77 56 68 83
PENTOXIFYLLINE 76 67 69 73
SPIRIVA 74 60 70 133
VYTORIN 74 50 70 132
PLAVIX 73 63 72 33
LANTUS 72 43 73 28
NAPROXEN 71 62 74 80
SUCRALFATE 70 53 75 120
DONEPEZIL HCL 68 68 76 50
DIPYRIDAMOLE 67 53 R 77 76
HUMULIN N 67 55 77 47
GLIPIZIDE 66 62 79 20
AZITHROMYCIN 63 45 80 55
FLUTICASONE PROPIONATE 61 34 81 66
COUMADIN 61 55 81 88
CIPROFLOXACIN HCL 61 51 81 54
NIFEDIPINE ER 59 58 84 75
LANSOPRAZOLE 58 44 85 72
MONTELUKAST SODIUM 57 38 86 156
GLIPIZIDE ER 56 54 87 85
DILTIAZEM ER 55 54 88 178
CETIRIZINE HCL 54 47 89 154
CYMBALTA 54 45 89 105
METOCLOPRAMIDE HCL 54 48 89 107
SPIRONOLACTONE 53 21 92 79
JANUMET 52 38 93 109
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.